• No results found

Calcification and C-reactive protein in atherosclerosis : effects of calcium blocking and cholesterol lowering therapy

N/A
N/A
Protected

Academic year: 2021

Share "Calcification and C-reactive protein in atherosclerosis : effects of calcium blocking and cholesterol lowering therapy"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Calcification and C-reactive protein in atherosclerosis : effects of

calcium blocking and cholesterol lowering therapy

Trion, A.

Citation

Trion, A. (2006, October 5). Calcification and C-reactive protein in atherosclerosis : effects

of calcium blocking and cholesterol lowering therapy. Retrieved from

https://hdl.handle.net/1887/4584

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4584

(2)

Calcification and C-reactive protein

in atherosclerosis

Effects of calcium blocking and cholesterol lowering

therapy

(3)
(4)

Calcification and C-reactive protein in

atherosclerosis

Effects of calcium blocking and cholesterol lowering therapy

PROEFSCHRIFT

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus Dr. D.D. Breimer,

hoogleraar in de faculteit Wiskunde en Natuurwetenschappen en die der Geneeskunde,

volgens besluit van het College voor Promoties te verdedigen op donderdag 5 oktober 2006

klokke 15.00 uur

door

Astrid Trion

(5)

Promotiecommissie

Promotores: Prof. dr. A. van der Laarse

Prof. dr. J.W. Jukema

Co-promotores: Dr. J.J. Emeis (TNO-Kwaliteit van Leven, Leiden) Dr. M.P.M. de Maat (Erasmus MC, Rotterdam)

Referent: Prof. dr. G. Pasterkamp (Universitair Medisch Centrum Utrecht)

Overige leden: Prof. dr. E.E. van der Wall Prof. dr. ir. L.M. Havekes Prof. dr. R.E. Poelmann

ISBN-10: 90-6464-030-0 ISBN-13: 978-90-6464-030-8

¤ A. Trion. Leiden, the Netherlands, 2006

(6)

“Realize that to question is how we grow”

Heather Small: 'Proud'

(7)

____________________________________________________________________________________________________

The research described in this thesis was performed at the Laboratory of Cardiobiochemistry of the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands, and at the Gaubius Laboratory of TNO Quality of Life, Leiden, the Netherlands.

Financial support by the Netherlands Heart Foundation for the publication of this thesis is gratefully acknowledged.

The printing of this thesis was also financially supported by the Dr. Ir. van de Laar Stichting.

(8)

_____________________________________________________________________________________________________

Contents

Chapter 1 Introduction 9

Chapter 2 Vascular smooth muscle cells and calcification in 29

atherosclerosis

American Heart Journal 2004; 147: 808-814

Chapter 3 In vitro calcification of neonatal vascular smooth muscle 45

cells

Submitted

Chapter 4 Modulation of calcification of vascular smooth muscle cells 63

in culture by calcium antagonists, statins, and their combination

Submitted

Chapter 5 C-reactive protein as a risk factor versus risk marker 83

Current Opinion in Lipidology 2004; 15: 651-657

Chapter 6 No effect of C-reactive protein on early atherosclerosis 99

development in ApoE*3-Leiden/hCRP transgenic mice

ATVB 2005; 25: 1635-1640

Chapter 7 Anti-atherosclerotic effect of amlodipine, alone and in 119

combination with atorvastatin, in ApoE*3-Leiden/hCRP transgenic mice

Journal of Cardiovascular Pharmacology 2006; 47: 89-95

Chapter 8 Summary and general discussion 139

Chapter 9 Samenvatting 145

Abbreviations 151

Nawoord 153

Curriculum Vitae 155

(9)

Referenties

GERELATEERDE DOCUMENTEN

Atherosclerosis is a chronic and multifactorial disease, which is characterized by different stages: I) the fatty streak, in which cholesterol is deposited in the vessel wall and

Another mechanism by which elevated Pi levels might stimulate calcification is through the induction of apoptosis in vascular cells. The hypothesis that Pi activates

In our model of vascular calcification, the amount of calcium deposition by neonatal rat VSMCs was positively correlated to the E-glycerophosphate concentration in the

Effect of a combination of CA and statin treatment on in vitro VSMC calcification VSMCs were incubated for 2-3 weeks in calcification medium supplemented with 0.1 Pmol/L

Upon incubation with CRP, endothelial cells from human coronary artery or human saphenous vein show increased expression of complement inhibitory factors 34.. These results

Although amlodipine treatment did not significantly lower cholesterol levels or blood pressure, it reduced lesion area by 43%, indicating that amlodipine has an

To investigate whether pharmacotherapy influences vascular calcification, we have studied whether a calcium antagonist (amlodipine) and a statin (atorvastatin) and their combination

Uit verschillende in vitro en in vivo studies is gebleken dat calcium antagonisten (CAs), die oorspronkelijk ontwikkeld en toegepast zijn als bloeddrukverlagende middelen, ook